| Nov 13 |
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal
|
| Nov 13 |
Amgen Rebounds, Shaking Off 'Overdone' Fears Tied To Its Weight-Loss Shot
|
| Nov 13 |
Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA
|
| Nov 12 |
Novo Nordisk A/S (NVO): A Bull Case Theory
|
| Nov 12 |
Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot
|
| Nov 12 |
Here's Why Novo Nordisk (NVO) is a Strong Growth Stock
|
| Nov 11 |
Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?
|
| Nov 11 |
Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.
|
| Nov 11 |
Novo Nordisk: Be Greedy When Others Are Fearful
|
| Nov 10 |
Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
|
